Cytomegalovirus infection and prophylaxis in renal transplantation: financial considerations.
Wright
F H
FH
San Antonio Community Hospital, Department of Transplantation, TX 78229, USA.
Banowsky
L H
LH
D000212:Acyclovir / Q000191:economics / Q000627:therapeutic use; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use; D002102:Cadaver; D003365:Costs and Cost Analysis; D003586:Cytomegalovirus Infections / Q000191:economics / Q000453:epidemiology* / Q000517:prevention & control; D006085:Graft Survival; D006764:Hospitals, Community; D006801:Humans; D016030:Kidney Transplantation / Q000191:economics* / Q000401:mortality / Q000502:physiology*; D019520:Living Donors; D011183:Postoperative Complications / Q000191:economics / Q000453:epidemiology; D015996:Survival Rate; D013781:Texas; D014019:Tissue Donors
D000998:Antiviral Agents; D000212:Acyclovir